Avalo Therapeutics, Inc.

BRAIDWELL LP AVTX

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/14/2026

Shares

1,629,182

Value ($000)

30,107

Weight

1.1%

2026 Q2 - 2026 Q2 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/14/2026	30,107	1.1%	1,629,182	6/30/2026